HpD photodynamic therapy for obstructing lung cancer.
Prog Clin Biol Res
; 170: 727-45, 1984.
Article
em En
| MEDLINE
| ID: mdl-6241710
ABSTRACT
Twenty-two patients with endobronchial cancer of the lungs have been treated with photoradiation therapy (PRT) employing a set protocol of 3.0 mg/kg hematoporphyrin derivative (HpD) administered intravenously 72 hours prior to red light (630 nm) illumination via a bronchoscope. Twenty patients showed a complete response. Of these, nineteen had large obstructing endobronchial tumors; one had a small mucosal lesion. Only one patient with an obstructing tumor showed a partial response. The one showing no response had an endobronchial mass that consisted of fibrous tissue, not tumor, as shown on three separate bronchoscopic biopsies.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fotoquimioterapia
/
Carcinoma
/
Hematoporfirinas
/
Neoplasias Pulmonares
Tipo de estudo:
Guideline
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Prog Clin Biol Res
Ano de publicação:
1984
Tipo de documento:
Article